eCARTv5 Clinical Deterioration Suite (eCART) vs TREWS (Targeted Real-Time Early Warning System)

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

TREWS (Targeted Real-Time Early Warning System)

by Bayesian Health

AI Verdict

Both AgileMD's eCARTv5 and Bayesian Health's TREWS are highly comparable AI-powered clinical decision support tools designed for early warning and risk stratification in hospitalized adult patients. While eCARTv5 focuses broadly on predicting clinical deterioration (death or ICU transfer) using up to 97 real-time variables, TREWS emphasizes the early detection of life-threatening events, with a notable focus on sepsis detection and reduction of associated mortality.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 if your primary goal is a comprehensive, all-cause prediction of clinical deterioration (death or ICU transfer) across a wide range of hospitalized adult patients. This tool excels at providing early warnings, often hours before critical illness, and integrates embedded clinical pathways to guide care based on continuous risk assessment.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose TREWS (Targeted Real-Time Early Warning System) if…

Choose TREWS if your focus is on an adaptive AI platform that delivers actionable clinical insights for specific life-threatening events, with a strong emphasis on sepsis detection and reduction in associated mortality. Its adaptive AI learns from clinician feedback and analyzes multi-modal patient data to provide real-time alerts and actionable insights within existing workflows.

View TREWS (Targeted Real-Time Early Warning System) →

When considering AI-powered clinical deterioration tools, eCARTv5 Clinical Deterioration Suite and TREWS (Targeted Real-Time Early Warning System) both offer robust solutions for early identification of at-risk patients. eCARTv5, from AgileMD, excels in continuously assessing and predicting the risk of death or ICU transfer in hospitalized adult patients, providing an eCART score and risk designation. Its strength lies in its embedded clinical pathways that guide care based on real-time EHR data, making it particularly suitable for institutions seeking a comprehensive, pathway-driven approach to managing patient deterioration.

Bayesian Health’s TREWS, on the other hand, focuses on intelligent care augmentation through adaptive AI, delivering actionable clinical insights for various life-threatening events beyond just deterioration, such as sepsis and pressure injuries. A key practical difference is TREWS’s adaptive AI that learns from clinician feedback, potentially offering more tailored and evolving insights over time. This makes TREWS a strong contender for organizations that prioritize a system that can continuously refine its alerts and insights based on local clinical practice and outcomes, aiming to reduce false alarms and alarm fatigue through ongoing learning.

Ultimately, the choice depends on the specific needs of the physician and institution. If the primary goal is a structured, pathway-guided approach to predicting and managing general clinical deterioration with a clear risk score, eCARTv5 is likely the better fit. However, if the preference is for an adaptive AI platform that learns and provides broader, actionable insights for a wider range of critical conditions, and can be refined through clinician feedback, TREWS would be the more appropriate selection.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	TREWS (Targeted Real-Time Early Warning System)
Pricing	Contact vendor for tailored quote.	Contact for pricing
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Cloud-based, integrated with hospital EHR systems.
FDA Status	1 AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools emphasize seamless integration with existing EHR systems and aim to reduce clinician workload and alarm fatigue. Without direct user feedback or detailed UI/UX specifications, it's difficult to definitively declare a winner in usability. Both claim to provide actionable insights within existing workflows.

Clinical Value

TREWS (Targeted Real-Time Early Warning System)

TREWS has demonstrated a statistically significant reduction in sepsis mortality by 18% when clinicians respond to alerts in a timely manner, and an 89% provider adoption rate. While eCARTv5 has strong retrospective and prospective validation for predicting clinical deterioration, including sepsis, heart failure, and COPD, and alerts a median of 5 hours in advance, it lacks a published direct mortality reduction claim.

Pricing & Value

Tie

Both AgileMD eCARTv5 and Bayesian Health TREWS offer enterprise-level solutions with custom pricing, requiring direct contact with the vendor for a tailored quote. Neither company provides publicly available pricing details, making a direct comparison of value for money impossible.

Enterprise Readiness

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCARTv5 highlights its deployment at over 400 hospitals with 150,000+ clinical users and 4,800+ pathways, suggesting a broader and more established enterprise footprint. Bayesian Health's TREWS has expanded its reach significantly and is deployed in multiple health systems, but specific numbers for hospitals or users are not as extensively detailed.

Innovation

TREWS (Targeted Real-Time Early Warning System)

Bayesian Health's TREWS features an 'adaptive AI that learns from clinician feedback,' which suggests a more dynamic and continuously improving system. While eCARTv5 uses a sophisticated gradient-boosted machine-learning model, the explicit mention of adaptive learning gives TREWS an edge in innovation.

Support & Docs

Tie

Both companies emphasize strong EHR integration and have a foundation of peer-reviewed research. However, neither company provides specific details about their customer support channels, service level agreements, or the comprehensiveness of their documentation in the provided information or readily available online sources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	TREWS (Targeted Real-Time Early Warning System)
Name	eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d)	TREWS (Targeted Real-Time Early Warning System)
Company	AgileMD	Bayesian Health
Key Feature 1	AI-powered clinical deterioration prediction	AI-driven early-warning clinical decision support
Key Feature 2	Continuous patient risk assessment (death or ICU transfer)	Real-time alerts for critical conditions (e.g., sepsis, pressure injuries)
Key Feature 3	EHR integration with real-time data (up to 97 variables)	Integrates with major EHRs (Epic, Cerner)
Key Feature 4	Embedded clinical pathways for care guidance	Adaptive AI that learns from clinician feedback

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and TREWS (Targeted Real-Time Early Warning System).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do eCARTv5 and TREWS integrate into existing physician workflows, and what is the learning curve for each?

eCARTv5 integrates directly into EHR systems, continuously assessing patient risk and guiding care with embedded clinical pathways. This aims to streamline decision-making within familiar interfaces. TREWS also integrates with major EHRs like Epic and Cerner, providing actionable clinical insights within existing workflows and automating chart abstraction and documentation. Both systems are designed to reduce clinician workload and minimize false alarms, suggesting a focus on ease of adoption and a manageable learning curve.

What is the depth of EHR integration for eCARTv5 and TREWS, and what data points do they leverage?

eCARTv5 integrates with EHRs to utilize up to 97 real-time variables, including laboratory results, vital signs, and nursing assessments, to generate an eCART score and risk designation. TREWS analyzes multi-modal patient data, including vitals, labs, and notes, and integrates with major EHRs such as Epic and Cerner. Both tools aim for deep integration to provide comprehensive patient risk assessment.

What are the reported accuracy and sensitivity metrics for eCARTv5 and TREWS, particularly in their respective clinical contexts?

eCARTv5 has demonstrated high accuracy, with an AUROC of 0.834 in retrospective validation, outperforming other early warning scores. It has been shown to alert medical staff a median of 5 hours before critical events. TREWS, specifically for sepsis, achieved an AUC of 0.97 in a retrospective cohort and identified 82% of sepsis cases. It also boasts a lower false-positive alert rate compared to some traditional sepsis alert systems.

Beyond general critical care and hospital medicine, are there specific clinical scenarios or patient populations where one tool might be more advantageous?

eCARTv5 is broadly focused on predicting all-cause clinical deterioration (death or ICU transfer) in hospitalized adult patients across diverse demographics and medical conditions. TREWS has a strong focus on early recognition of sepsis, with studies demonstrating its effectiveness in identifying sepsis patients earlier and improving outcomes. Therefore, for institutions with a primary focus on sepsis management, TREWS might offer a more targeted advantage, while eCARTv5 provides a broader deterioration prediction.

What kind of support and resources are available for physicians during the initial implementation and ongoing use of eCARTv5 and TREWS?

While specific details on support quality are not explicitly stated for either tool, both companies emphasize their solutions are enterprise-level and require tailored quotes, suggesting a consultative approach to implementation. TREWS's adaptive AI learns from clinician feedback, implying an ongoing refinement process that could involve direct support. eCARTv5's development involved extensive research and validation, indicating a robust underlying framework that would likely be supported by the vendor.